We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLXS icon
2226
Flexsteel Industries
FLXS
$303M
$470K ﹤0.01%
12,600
MRTN icon
2227
Marten Transport
MRTN
$1.24B
$470K ﹤0.01%
25,415
+2,065
+9% +$39.7K
CLB icon
2228
Core Laboratories
CLB
$569M
$469K ﹤0.01%
27,450
+2,070
+8% +$32.6K
CASH icon
2229
Pathward Financial
CASH
$1.79B
$464K ﹤0.01%
9,180
+963
+12% +$48.9K
TBI
2230
Trueblue
TBI
$309M
$464K ﹤0.01%
36,983
+7,417
+25% +$95.9K
NWPX icon
2231
NWPX Infrastructure Inc
NWPX
$1.11B
$462K ﹤0.01%
13,309
+598
+5% +$18.3K
EGY icon
2232
Vaalco Energy
EGY
$592M
$458K ﹤0.01%
65,678
+4,590
+8% +$21.5K
WNEB icon
2233
Western New England Bancorp
WNEB
$282M
$458K ﹤0.01%
59,650
KRNY icon
2234
Kearny Financial
KRNY
$604M
$457K ﹤0.01%
70,851
+5,272
+8% +$36.9K
CNDT icon
2235
Conduent
CNDT
$252M
$456K ﹤0.01%
134,884
+7,890
+6% +$27.4K
GOGL
2236
DELISTED
Golden Ocean Group
GOGL
$456K ﹤0.01%
35,144
+4,858
+16% +$55.8K
NOVA
2237
DELISTED
Sunnova Energy
NOVA
$456K ﹤0.01%
74,332
+11,361
+18% +$102K
TTI icon
2238
TETRA Technologies
TTI
$1.25B
$456K ﹤0.01%
102,722
+5,265
+5% +$21.9K
RYZ
2239
Ryerson Holding Corp
RYZ
$1.5B
$455K ﹤0.01%
13,553
+977
+8% +$32K
ADTN icon
2240
Adtran
ADTN
$658M
$453K ﹤0.01%
83,155
+2,764
+3% +$17.6K
CRGY icon
2241
Crescent Energy
CRGY
$3.93B
$453K ﹤0.01%
37,999
+2,692
+8% +$30.3K
SSTK icon
2242
Shutterstock
SSTK
$217M
$452K ﹤0.01%
9,853
+874
+10% +$41.6K
SPCE icon
2243
Virgin Galactic
SPCE
$475M
$451K ﹤0.01%
15,215
+2,083
+16% +$75.6K
DHT icon
2244
DHT Holdings
DHT
$3.09B
$450K ﹤0.01%
39,082
+4,836
+14% +$53K
CHCT
2245
Community Healthcare Trust
CHCT
$433M
$444K ﹤0.01%
16,686
+919
+6% +$24.2K
NTB icon
2246
Bank of N.T. Butterfield & Son
NTB
$2.51B
$444K ﹤0.01%
13,858
+1,576
+13% +$47.9K
TBPH icon
2247
Theravance Biopharma
TBPH
$878M
$444K ﹤0.01%
49,475
+3,532
+8% +$32.7K
EHAB
2248
DELISTED
Enhabit
EHAB
$443K ﹤0.01%
37,950
+2,078
+6% +$20.8K
FCBC icon
2249
First Community Bankshares
FCBC
$933M
$443K ﹤0.01%
12,781
+539
+4% +$18.3K
FOR icon
2250
Forestar Group
FOR
$1.51B
$442K ﹤0.01%
10,997
+781
+8% +$26.5K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.